Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
French Study Group on Chronic Lymphoid Leukemia
With
Lymphoma Study Association
French Innovative Leukemia Organisation
Département de Biostatistiques et Informatique Médicale DBIM
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Established diagnosis of Waldenström macroglobulinemia (the 2nd Workshop on Waldenstrom's macroglobulinemia) or Lymphoplasmacytic lymphoma or Splenic Marginal Zone Lymphoma, needing a treatment
Life expectancy \> 6 months
Creatinine \< 200 µmol/l
SGPT and SGOT \< 2x ULN
A negative direct Coombs test
Written informed consent
You may not be if
Past chemotherapy/radiotherapy/immunotherapy prior to the study for Waldenström macroglobulinemia
Previous malignancy less than 5 years ago except carcinoma in situ of the cervix and non-melanoma skin cancer
Positive HIV serology
Active Hepatitis B or C
Lactation/pregnancy
Impossible good compliance with the study protocol
Active infection not controlled
Psychological condition hampering understanding of the study
